A differential cell capture assay for evaluating antibody interactions with cell surface targets

Analytical Biochemistry

Volumn 401, Issue 2, 2010, Pages 173-181

  Sherman, David J ^a   Kenanova, Vania E ^a   Lepin, Eric J ^a   McCabe, Katelyn E ^a   Kamei, Ken ichiro ^a   Ohashi, Minori ^a   Wang, Shutao ^a   Tseng, Hsian Rong ^a   Wu, Anna M ^a   Behrenbruch, Christian P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody; Biotin; CD20; Cell capture; ELISA; Flow cytometry; Fluorescence microscopy; Mammalian cell; Streptavidin

Indexed keywords

ANTIBODIES; BINDING ENERGY; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MAMMALS; MONOCLONAL ANTIBODIES;

BIOTIN; CD20; CELL CAPTURE; ELISA; MAMMALIAN CELLS; STREPTAVIDIN;

CELL MEMBRANES;

CD20 ANTIBODY; RITUXIMAB;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CELL ASSAY; CELL CAPTURE ASSAY; CELL SURFACE; CHIMERA; CONTROLLED STUDY; DAUDI CELL; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MICROSCOPY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; TARGET CELL;

MAMMALIA; MURINAE;

EID: 77952885663     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.02.015     Document Type: Article

References (39)

1. Wu A.M., Senter P.D. Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol. 2005, 23:1137-1146.
2. Filpula D. Antibody engineering and modification technologies. Biomol. Eng. 2007, 24:201-215.
3. Baselga J., Norton L., Albanell J., Kim Y.-M., Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 1998, 58:2825-2831.
4. 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT 84.66 minibody) in patients with colorectal cancer. Clin. Cancer Res. 2004, 10:5014-5021.
5. Jiao J., Wang S., Qiao R., Vivanco I., Watson P.A., Sawyers C.L., Wu H. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res. 2007, 67:6083-6091.
6. Michelini E., Leskinen P., Virta M., Karp M., Roda A. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Biosens. Bioelectron. 2005, 20:2261-2267.
7. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
8. Krutzik P.O., Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003, 55:61-70.
9. Versteeg H.H., Nijhuis E., van den Brink G.R., Evertzen M., Pynaert G.N., van Deventer S.J.H., Coffer P.J., Peppelenbosch M.P. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), protein kinase B, and cAMP-response-element-binding protein. Biochem. J. 2000, 350:717-722.
10. Hulspas R., Quesenberry P.J. Characterization of neurosphere cell phenotypes by flow cytometry. Cytometry 2000, 40:245-250.
11. MacDonald K.P.A., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N.J. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
12. McCluggage W.G. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 2002, 40:309-326.
13. Falati S., Gross P., Merrill-Skoloff G., Furie B.C., Furie B. Real-time in vivo imaging of platelets, tissue factor, and fibrin during arterial thrombus formation in the mouse. Nat. Med. 2002, 8:1175-1180.
14. Sipkins D.A., Wei X., Wu J.W., Runnels J.M., Cote D., Means T.K., Luster A.D., Scadden D.T., Lin C.P. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005, 435:969-973.
15. Macdonald R.A., Hosking C.S., Jones C.L. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Methods 1988, 106:191-194.
16. Zhao Q., Lu H., Schols D., de Clercq E., Jiang S. Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4. AIDS Res. Hum. Retroviruses 2003, 19:947-955.
17. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 1994, 12:433-455.
18. Goldblatt D., van Etten L., van Milligen F.J., Aalberse R.C., Turner M.W. The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity. J. Immunol. Methods 1993, 166:281-285.
19. Nolan J.P., Sklar L.A. The emergence of flow cytometry for sensitive, real-time measurements of molecular interactions. Nat. Biotechnol. 1998, 16:633-638.
20. Benedict C.A., MacKrell A.J., Anderson W.F. Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J. Immunol. Methods 1997, 201:223-231.
21. Geuijen C.A.W., Clijsters-van der Horst M., Cox F., Rood P.M.L., Throsby M., Jongeneelen M.A.C., Backus H.H.J., van Deventer E., Kruisbeek A.M., Goudsmit J., de Kruif J. Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery. J. Immunol. Methods 2005, 302:68-77.
22. Boder E.T., Midelfort K.S., Wittrup K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. USA 2000, 97:10701-10705.
23. O'Shannessy D.J., Brigham-Burke M., Soneson K.K., Hensley P., Brooks I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal. Biochem. 1993, 212:457-468.
24. Homola J. Present and future of surface plasmon resonance biosensors. Anal. Bioanal. Chem. 2003, 377:528-539.
25. + T-cell counting microchip through monocyte depletion for HIV/AIDS diagnostics. Lab Chip 2009, 9:1357-1364.
26. Sekine K., Revzin A., Tompkins R.G., Toner M. Panning of multiple subsets of leukocytes on antibody-decorated poly(ethylene) glycol-coated glass slides. J. Immunol. Methods 2006, 313:96-109.
27. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., Smith M.R., Kwak E.L., Digumarthy S., Muzikansky A., Ryan P., Balis U.J., Tompkins R.G., Haber D.A., Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
28. Roupioz Y., Berthet-Duroure N., Leichle T., Pourciel J.-B., Mailley P., Cortes S., Villiers M.-B., Marche P.N., Livache T., Nicu L. Individual blood-cell capture and 2D organization on microarrays. Small 2009, 5:1493-1497.
29. Soen Y., Chen D.S., Kraft D.L., Davis M.M., Brown P.O. Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol. 2003, 1:429-438.
30. Hood L., Heath J.R., Phelps M.E., Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306:640-643.
31. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 1997, 105:70-76.
32. Poortman J., Vroegindewey-Jie D., Thijssen J.H.H., Schwarz F. Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue. Mol. Cell. Endocrinol. 1977, 8:27-34.
33. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 1990, 39:9-12.
34. Uchiyama S., Suzuki Y., Otake K., Yokoyama M., Ohta M., Aikawa S., Komatsu M., Sawada T., Kagami Y., Morishima Y., Fukui K. Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope. Cancer Sci. 2009, 101:201-209.
35. Peluso P., Wilson D.S., Do D., Tran H., Venkatasubbaiah M., Quincy D., Heidecker B., Poindexter K., Tolani N., Phelan M., Witte K., Jung L.S., Wagner P., Nock S. Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal. Biochem. 2003, 312:113-124.
36. Du J., Wang H., Zhong C., Peng B., Zhang M., Li B., Huo S., Guo Y., Ding J. Structural basis for recognition of CD20 by therapeutic antibody rituximab. J. Biol. Chem. 2007, 282:15073-15080.
37. Binder M., Otto F., Mertelsmann R., Vellken H., Trepel M. The epitope recognized by rituximab. Blood 2006, 108:1975-1978.
38. Wacker R., Schroder H., Niemeyer C.M. Performance of antibody microarrays fabricated by either DNA-directed immobilization, direct spotting, or streptavidin-biotin attachment: a comparative study. Anal. Biochem. 2004, 330:281-287.
39. Jung Y., Jeong J.Y., Chung B.H. Recent advances in immobilization methods of antibodies on solid supports. Analyst 2008, 133:697-701.